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Abstract 21 
Objective: To describe variations in surgical technique and caval occlusions times in 22 
dogs undergoing adrenalectomy with caval venotomy. 23 
Study Design: Retrospective case series. 24 
Animals: Dogs undergoing adrenalectomy with caval venotomy from 2010 to 2018. 25 
Methods: Medical records of dogs undergoing adrenalectomy with caval venotomy were 26 
reviewed for signalment, perioperative management, surgical details, perioperative 27 
complications, mortality, and histopathology. Computed tomography images were 28 
reviewed to describe tumor morphology and signs of thrombus extension.  29 
Results: There were 19 dogs with adrenal tumor thrombi extending into the pre-hepatic 30 
(14 dogs, 74%), hepatic (3 dogs, 16%) and post-hepatic (2 dogs, 11%) caudal vena cava. 31 
The left adrenal gland (58%) was more commonly affected than the right (42%). Median 32 
caval occlusion was 6.5 minutes, ranging from 2 to 25 minutes. Between two and six 33 
vascular tourniquets were used. Venotomy closure was performed under full caval 34 
occlusion in 58% and using a partial occlusion clamp in 42%. Left ureteronephrectomy 35 
was performed in 26%. Peri-operative mortality rate was 21%. 36 
Conclusions: Ureteronephrectomy is much more likely to be required on the left side. 37 
Venotomy closure under full occlusion was performed more commonly for right adrenal 38 
tumors. Number of vascular tourniquets used reflected the location of phrenicoabdominal 39 
vein insertion on the cava and length of the caval tumor thrombus. Longer caval 40 
occlusion than previously reported may be tolerated in some clinical cases.  41 
  
Clinical Significance: Review of surgical technique for adrenalectomy with caval 42 
venotomy, including differences between right and left tumors, should provide useful 43 
information for surgeons planning this procedure.  44 
  
Introduction 45 
Extension of a tumor thrombus into the caudal vena cava (CVC) is reported in canine 46 
pheochromocytomas and adrenocortical adenocarcinomas. This finding adds complexity 47 
to the surgical procedure, and extends the surgical time because of the need for venotomy 48 
to remove the intracaval tumor thrombus (Figure 1).1-2 There is conflicting data in the 49 
literature regarding CVC thrombus extension as a possible risk factor for perioperative 50 
mortality during adrenalectomy, probably reflecting variations in the extent of CVC 51 
thrombus between studies.2-7 Also, there are few descriptions of the nature and extent of 52 
CVC invasion or the surgical techniques required to treat this, such as use of vascular 53 
tourniquets, partial versus complete occlusion, and methods of venotomy closure. There 54 
are no clinical studies that report the caval occlusion times required or tolerated during 55 
venotomy by any technique for dogs undergoing adrenalectomy. 56 
 57 
One report of 10 dogs with adrenal tumors described the extent of CVC thrombus; eight 58 
dogs with pre-hepatic and one dog with an intra-hepatic CVC thrombus were treated by 59 
temporary CVC occlusion using two vascular tourniquets followed by CVC venotomy 60 
closure over a partial occlusion clamp, and one dog with an extensive intra-hepatic CVC 61 
thrombus, which was deemed non-resectable, died during surgery.2 In a larger study of 62 
27 dogs with adrenal tumors invading the CVC, some dogs had a venotomy entirely 63 
performed over a partial occlusion clamp and others had venotomy closure over a partial 64 
occlusion clamp after the thrombus had been removed under full CVC occlusion.4 The 65 
details of how many dogs were treated by each method, the number and location of 66 
vascular tourniquets, the duration of CVC occlusion and extent of the CVC thrombus 67 
  
(pre, intra or post-hepatic CVC) were not reported.4 In another report, three dogs had a 68 
CVC venotomy closed over a partial occlusion clamp.1 The extent of tumor thrombi in 69 
these three dogs was not described, but two dogs also received a median sternotomy to 70 
help “milk” the tumor thrombus out through an abdominal CVC incision, which was 71 
performed separately to the adrenalectomy, i.e. the thrombus was not removed en bloc 72 
with the primary adrenal tumour.1 In two reports, CVC venotomies for adrenal tumor 73 
removal were performed under full CVC occlusion, although neither describe the extent 74 
of the CVC invasions.5,6 One study described seven dogs with adrenal tumor thrombus 75 
extension confined to the pre-hepatic CVC and seven dogs with CVC thrombus 76 
extending beyond the hepatic hilus, but no details of the surgical techniques used to 77 
excise the thrombi were included.3  78 
 79 
The degree of thrombus extension (pre-hepatic, hepatic, post-hepatic), affected adrenal 80 
(left or right), location of the insertion of the phrenicoabdominal vein on the CVC (Figure 81 
2), width of the phrenicoabdominal vein (distended by tumor) and type of tumor invasion 82 
into the CVC (direct phrenicoabdominal vein extension, direct CVC wall invasion or 83 
extension via the renal vein) affects the complexity that extraction of the tumor via CVC 84 
venotomy represents and thus the surgical techniques employed, including the number 85 
and location of tourniquets for CVC occlusion (Figures 3 and 4), length of CVC 86 
occlusion time and choice of venotomy technique. The aim of the present study was to 87 
describe variations in surgical technique, with a rationale for doing so where appropriate, 88 
and the duration of temporary CVC occlusion in a series of dogs undergoing 89 
adrenalectomy with CVC venotomy for treatment of adrenal neoplasia.  90 
  
Materials and Methods 91 
Medical records were searched for dogs that had adrenalectomy with CVC venotomy for 92 
treatment of primary adrenal gland neoplasia between October 2010 and May 2018. Dogs 93 
were included if CVC venotomy was performed for adrenal tumor thrombectomy and 94 
pre-operative computed tomography (CT) images were available for review. Dogs with 95 
adrenal tumors and phrenicoabdominal vein invasion treated by adrenalectomy with 96 
phrenicoabdominal vein ligation only were excluded. Details of signalment, presenting 97 
clinical signs, pre-operative endocrine testing, pre-operative medication, anesthetic 98 
management and surgical technique (including number and location of tourniquets, 99 
length of CVC occlusion time and venotomy closure method), hospitalization time, 100 
perioperative complications, mortality, and histopathological analysis were recorded.  101 
Pre-operative CT examinations were acquired using a multi-slice scanner (MX8000 IDT, 102 
Phillips, Best, The Netherlands) and images reviewed using a proprietary DICOM viewer 103 
(Image Viewer Version 4.1, Visbion Ltd, Chertsey, UK). CT settings were helical 104 
acquisition, slice thickness up to 3mm, medium frequency (‘soft tissue’) reconstruction 105 
algorithm, with post-contrast CT images acquired 60 seconds after the start of 106 
intravenous injection of 2ml/kg of iohexol 300mg/ml (Omnipaque 300, GE Healthcare, 107 
Oslo, Norway). CT images were reviewed by a board-certified radiologist to determine 108 
size, shape and attenuation (Hounsfield units, HU) of the primary tumor, extent of 109 
vascular invasion, signs of invasion of other structures, and signs of metastasis. Length of 110 
extension of tumor thrombus into the CVC was categorized as pre-hepatic, hepatic or 111 
post-hepatic CVC. 112 
 113 
  
Pre-operative Management 114 
Initial evaluation included complete blood count, biochemistry and urine analysis. 115 
Endocrine testing was performed using the adrenocorticotropic hormone (ACTH) 116 
stimulation test, low-dose dexamethasone suppression test, urine cortisol to creatinine 117 
ratio, and measurement of serum metanephrine and normetanephrine levels. Abdominal 118 
ultrasound was used in some cases for identification of the adrenal tumor, with thoracic 119 
and abdominal CT performed in all dogs for staging and surgical planning. Based on the 120 
results of endocrine testing dogs were treated medically prior to surgery with trilostane (if 121 
hyperadrenocorticism was confirmed) or phenoxybenzamine (if a pheochromocytoma 122 
was confirmed or suspected). 123 
 124 
Anesthetic Management 125 
The anesthetic protocol was tailored for each dog at the discretion of a board-certified 126 
anesthesiologist. Cefuroxime or amoxicillin-clavulanate (20mg/kg intravenously [IV]) 127 
was administered at least 20 minutes prior to the first incision and every two hours during 128 
general anesthesia. Dogs with a cortisol secreting tumor were administered a constant 129 
rate intravenous infusion of hydrocortisone at 0.5 mg/kg/h from one hour pre-operatively 130 
and throughout surgery. Severe intra-operative hypertension and/or arrhythmias were 131 
treated with nitroprusside or lidocaine if necessary. Management of hypotension was by 132 
rapid expansion of volume by crystalloids, colloids and/or blood products, as well as 133 
administration of dopamine, dobutamine or epinephrine when required. 134 
 135 
Surgery 136 
  
A ventral midline celiotomy and full abdominal exploration was performed in all dogs, 137 
with extension to a median sternotomy in one dog. The adrenal mass was isolated from 138 
the surrounding tissues using a combination of blunt and sharp dissection with Mixter 139 
forceps, Metzenbaum scissors, hemoclips and diathermy until the only remaining 140 
attachment was the insertion of the phrenicoabdominal vein on the CVC (Figure 3). Left-141 
sided tumors were passed underneath the mesentery so as to be the same side of the 142 
abdomen as the CVC to optimize exposure for the venotomy (Figure 4). Rummel 143 
tourniquets were placed around the abdominal CVC cranial and caudal to the tumor 144 
thrombus (Figure 3) and in some cases around one or both renal veins (Figure 4), the 145 
thoracic CVC and the portal vein and hepatic artery together at the level of the epiploic 146 
foramen (Pringle maneuver) depending on the location of insertion of the 147 
phrenicoabdominal vein on the CVC and the extent of the CVC thrombus. The plan for 148 
the CVC occlusion, venotomy and vein closure was summarized by the lead surgeon and 149 
confirmed with the surgical and anesthesia teams before starting the theatre clock for 150 
timing of the CVC occlusion. Renal vein tourniquets were tightened before CVC 151 
tourniquets, and caudal CVC were tightened before cranial CVC tourniquets. CVC 152 
venotomy was performed using a combination of a number 11 scalpel and Potts scissors 153 
around the insertion of the phrenicoabdominal vein and extended along the CVC as 154 
required to allow removal of the tumor thrombus. Some venotomy closures were 155 
performed under partial occlusion with a tangential clamp placed parallel to the incision 156 
and the Rummel tourniquets released, taking care that the edges of the vein within the 157 
clamp were matched correctly to each other and sufficiently wide to accept good bites of 158 
suture.  Alternatively, some venotomies were sutured under complete CVC occlusion, in 159 
  
which case the starting knot of the continuous suture pattern was pre-placed and tied 160 
prior to starting the CVC occlusion and performing the venotomy. Venotomies were 161 
closed under complete CVC occlusion if the venotomy was too large for the tangential 162 
clamp to be placed around it or if the location of the phrenicoabdominal vein insertion 163 
and subsequent venotomy precluded space for a clamp. A single or double simple 164 
continuous suture line with 4-0, 5-0 or 6-0 polypropylene was used for venotomy closure, 165 
with an absorbable hemostatic agent (Surgicel, Ethicon, Somerville, NJ) applied in some 166 
dogs at the discretion of the surgeon. Concurrent ureteronephrectomy was performed in 167 
some dogs during initial dissection of the adrenal tumor due to tumor invasion of the 168 
kidney (Figure 5) and/or renal vein or, at a later stage, due to irreparable damage to the 169 
renal vein during CVC venotomy. 170 
 171 
Post-operative Care 172 
All dogs were monitored in the intensive care unit post-operatively until fully recovered 173 
from anesthesia and considered stable enough to be transferred to the surgical ward until 174 
discharge from the hospital. Post-operative analgesia was provided at the discretion of the 175 
anesthesiologist, based on pain scoring.8 Dogs with a cortisol secreting tumor had their 176 
constant rate intravenous infusion of hydrocortisone reduced to 0.25 mg/kg/h at the end 177 
of surgery and continued for a further 24 hours. Oral prednisolone treatment was then 178 
initiated, with dosing gradually tapered over the following months based on progress at 179 
re-examination and subsequent ACTH stimulation tests. Dogs on pre-operative 180 
phenoxybenzamine did not continue with this medication post-operatively.  181 
  
Results 182 
Signalment and Presentation 183 
Nineteen dogs met the inclusion criteria for the study; 10 were males (9 neutered), and 9 184 
were females (8 neutered). Median age was 11.3 years (range 6.7-14 years) and median 185 
bodyweight was 12.2 kg (range 5.7-41.3 kg). Thirteen breeds were represented and there 186 
were six crossbreeds. There were ten males (nine neutered) and nine females (eight 187 
neutered) dogs. Presenting clinical signs, complete blood count, biochemistry testing and 188 
urine analysis were largely non-specific and consistent with other reports of dogs 189 
presenting with functional adrenal tumors. Endocrine testing confirmed 190 
hyperadrenocorticism in three dogs (16%), was consistent with pheochromocytoma in 14 191 
dogs (74%), with a progesterone-secreting tumor in one dog (5%) and with a non-192 
functional tumor in one dog (5%). Dogs with hyperadrenocorticism were treated with 193 
trilostane pre-operatively, with a median dose of 2 mg/kg (range 1.4-2.4 mg/kg) once 194 
daily. Twelve of 14 dogs with suspected pheochromocytoma were treated with 195 
phenoxybenzamine, with a median dose of 0.5 mg/kg (range 0.27-2.5 mg/kg) twice daily 196 
for between 4 and 21 days pre-operatively.  197 
 198 
Diagnostic Imaging 199 
Thoracic and abdominal CT was performed in all dogs, as per the inclusion criteria. The 200 
left adrenal gland (11 dogs, 58%) was more frequently affected than the right (eight dogs, 201 
42%). Median transverse diameter of adrenal neoplasms on CT was 22 mm (range 12-63 202 
mm). The contralateral adrenal gland was considered normal size in 68%, subjectively 203 
enlarged in 16% and subjectively small (compatible with atrophy) in 16% cases. On the 204 
  
basis of CT, neoplasms were rounded (14/19) or lobular (5/19), all except one had a well-205 
defined outline, 12 of 19 dogs had a regular border, 4 of 19 had an irregular border, and 3 206 
of 19 had signs of infiltration into the adjacent retroperitoneal fat. According to pre-207 
contrast CT images, adrenal tumors appeared homogeneous (12/19, heterogeneous (1/19) 208 
or calcified (7/19). The median pre-contrast attenuation was 48 HU (range 39-67 HU) 209 
and median post-contrast attenuation was 102 HU (range 44-220 HU), with a median 210 
increase of 47 HU (range 10-162 HU) after contrast administration. Degree of contrast 211 
enhancement was classified as slight (<60 HU) in 13 of 19, moderate (60-110 HU) in 4 of 212 
19, and marked (>110 HU) in 2 of 19 dogs. After contrast administration, adrenal tumors 213 
appeared equally homogeneous (9/19) and heterogeneous (10/19).  214 
 215 
Extension of tumor into the CVC and phrenicoabdominal vein was visible on the CT in 216 
all dogs, with left renal vein invasion identified in 16% (three dogs), all with 217 
pheochromocytomas. On the basis of the extent of the intraluminal filling defect in post-218 
contrast images, the thrombus extended to the pre-hepatic (14 dogs, 74%), hepatic (3 219 
dogs, 16%) or post-hepatic (2 dogs, 11%) CVC, with a median length 15 mm (range 3-220 
120 mm) cranial to the adrenal mass. In one dog the thrombus completely obstructed the 221 
CVC. There was evidence of tumor invasion into the adjacent retroperitoneum in one 222 
dog, and invasion into the diaphragm and epaxial muscles in one dog.   223 
 224 
Surgical Details 225 
Surgery was performed by four board-certified surgeons, with one surgeon performing 226 
nine procedures, one performing six procedures, and the remaining two surgeons each 227 
  
performed two procedures. Median surgical time was 190 minutes (range 130-420 228 
minutes) and median anesthetic time was 265 mins (range 190-490 mins). Regional 229 
analgesia was provided with epidural morphine in 14 dogs and a transverse abdominis 230 
plane block using ropivacaine in two dogs. Methadone (0.1-0.3 mg/kg IV) was 231 
administered to all dogs perioperatively and 14 dogs also received a fentanyl or 232 
remifentanil constant rate infusion intra-operatively. A single dose of heparin sodium 233 
solution for injection (50 I.U./kg [IV]) was administered to all dogs 5-10 minutes before 234 
starting the CVC venotomy. 235 
 236 
Two Rummel tourniquets were used on the pre-hepatic CVC cranial and caudal to the 237 
thrombus (Figure 3) in 11 of 19 dogs (58%), four left sided and seven right sided tumors. 238 
Three Rummel tourniquets with an additional tourniquet on the left renal vein were used 239 
in one dog (5%) with a left adrenal tumor. Four Rummel tourniquets around the pre-240 
hepatic CVC and both renal veins (Figure 4) were used in six dogs, (32%), all with left 241 
adrenal tumors. Six tourniquets were placed in one dog with a right adrenal tumor, with 242 
the additional Rummel tourniquets placed on the post-hepatic thoracic CVC and portal 243 
vein and hepatic artery together at the level of the epiploic foramen (Pringle maneuver). 244 
Overall median CVC occlusion time (n = 15) was 6.5 minutes (range 2 to 25 minutes). 245 
Median CVC occlusion time for venotomies sutured over a partial occlusion clamp (n = 246 
5) was 3.83 minutes (range 2 to 5.5 minutes). Median CVC occlusion time for 247 
venotomies sutured under full occlusion was 7.88 minutes (range 6 to 25 minutes). Four 248 
dogs had extended CVC occlusion times of 9.85, 10, 17 and 25 minutes. The extended 249 
occlusion time of 9.85 minutes in one dog result from blockage of the suction machine 250 
  
and subsequent poor visibility during the venotomy. The occlusion times of 10, 17, and 251 
25 minutes in three other dogs resulted from the extensive nature or length of the tumor 252 
thrombus requiring additional time to remove the tumor thrombus and perform the 253 
venotomy. 254 
 255 
CVC venotomy closure was performed under complete occlusion in 11 dogs (58%), five 256 
left sided and six right sided tumors.  CVC venotomy closure was performed under 257 
partial occlusion with a tangential clamp in 8 of 19 dogs (42%), six left sided and two 258 
right sided tumors. Closure was performed with 4-0 (1 dog; 5%), 5-0 (14 dogs; 74%), or 259 
6-0 (4 dogs; 21%) polypropylene in a single (13 dogs; 68%) or double (6 dogs; 32%) 260 
simple continuous pattern. An absorbable hemostatic agent (Surgicel, Ethicon) was 261 
applied over the suture line in 12 dogs (63%). 262 
 263 
Concurrent left ureteronephrectomy was performed in five dogs (26%) due to extension 264 
of the tumor thrombus into the left renal vein (one dog), tumor growth incorporating the 265 
left renal vein and kidney (two dogs) (Figure 5), and intra-operative damage to the left 266 
renal vein (two dogs). One dog with a right sided tumor required resection of a portion of 267 
the diaphragm to facilitate dissection of a large primary adrenal mass.  268 
 269 
Histopathology was performed in 17 dogs, which confirmed pheochromocytomas (12 270 
dogs; 71%) and adrenocortical adenocarcinomas (5 dogs; 29%). Vascular invasion was 271 
evident on histopathology in all tumors, with one dog having direct invasion through the 272 
CVC wall as well as via extension from the phrenicoabdominal vein. 273 
  
 274 
Perioperative Complications and Mortality 275 
Intra-operative complications were observed in 14 of 19 dogs (74%), including 276 
hypotension (n=12), hypertension (n=2), arrhythmias (n=3) hemorrhage (n=6), break in 277 
asepsis (n=1), and temporary jejunal ischemia due to occlusion of the cranial mesenteric 278 
artery during dissection of large left sided tumors that enveloped this artery (n =2) 279 
(Figure 6).  Packed red blood cell transfusions were performed in five dogs after intra-280 
operative hemorrhage, and two dogs received fresh frozen plasma. One dog died intra-281 
operatively at the end of surgery after excision of the tumor and thrombus; the adrenal 282 
tumor was large and highly adherent, requiring prolonged dissection. There were multiple 283 
periods of hypotension and ventricular arrhythmias, which progressed to ventricular 284 
fibrillation and cardiopulmonary arrest. Resuscitation was attempted but was 285 
unsuccessful. 286 
 287 
Post-operative complications occurred in 13 of 18 dogs (68%) including refractory 288 
hypotension (n=2), acute kidney injury (n=2), and one each of: pulmonary 289 
thromboembolism, hemoperitoneum, aspiration pneumonia, hypovolemia, self-resolving 290 
peripheral edema, persistent hypertension, a single episode of abdominal pain, and 291 
anorexia with hypoglycemia. Refractory hypotension developed in one dog immediately 292 
post-operatively on recovery from anesthesia and in another a few hours post-operatively. 293 
Both cases progressed to cardiac arrest and resuscitation was unsuccessful. Pulmonary 294 
thromboembolism was confirmed on post-mortem examination in one dog following 295 
respiratory arrest four days post-operatively. Repeat exploratory laparotomy was 296 
  
performed in the dog with hemoperitoneum, in which a retroperitoneal hematoma was 297 
found near the site of ureteronephrectomy, but no specific source of hemorrhage could be 298 
identified (the renal vessel pedicles and CVC venotomy sites were not bleeding). 299 
Autotransfusion was performed and the dog recovered with no further complications.  300 
 301 
Median time to discharge was four days (range 3-11 days), and median time in the 302 
intensive care unit was two days (range 1-5 days). The 4 dogs with prolonged CVC 303 
occlusion times all survived to discharge. Overall perioperative mortality rate was 21% 304 
(four dogs). These dogs all had pheochromocytomas, with a median tumor size 28 mm 305 
(range 20-63 mm). The CVC thrombi were all pre-hepatic in these four dogs, extending 306 
3-13 mm cranial to the adrenal mass. No dogs were euthanized intra-operatively due to 307 
the technical difficulties or the tumor being considered inoperable.  308 
  
Discussion 309 
This report describes variations in surgical technique in dogs undergoing adrenalectomy 310 
with CVC venotomy for treatment of adrenal neoplasia, including the duration of 311 
temporary CVC occlusion tolerated. CVC occlusion for up to eight minutes has been 312 
reported to be safe in healthy experimental dogs,9 but there is no information regarding 313 
CVC occlusion times in dogs with adrenal tumors. Most dogs in this study had a CVC 314 
occlusion time less than eight minutes, but four dogs had longer occlusion times of 9.85, 315 
10, 17 and 25 minutes. These dogs all survived to discharge, suggesting that longer 316 
occlusion may be tolerated in selected patients, without adverse effects, presumably 317 
because in many cases gradual occlusion of the CVC to a significant extent by the tumor 318 
prior to surgery affords a degree of tolerance to full temporary occlusion during surgery. 319 
Further investigation is needed to determine safe or optimal CVC occlusion times in 320 
clinical patients and to improve our understanding of the factors involved.  321 
 322 
Left (11/19) adrenal tumors occurred more frequently than right (42%) in this study, 323 
similar to one other report,5 but not others.2,3,6,10 A difference for surgeons to note when 324 
operating on left sided adrenal tumors, which is likely performed by others but has not 325 
been reported before, is the need to move the dissected out left adrenal tumor over to the 326 
right side of the abdomen prior to CVC venotomy to optimize exposure for this part of 327 
the procedure (Figure 4). The use of more than two Rummel tourniquets for vascular 328 
occlusion in dogs undergoing CVC venotomy for removal of adrenal tumors has also not 329 
been reported before, although it may seem an obvious possibility (Figure 4). The more 330 
distal insertion of the left phrenicoabdominal in close proximity to the left renal vein 331 
  
insertion on the CVC (Figure 2) and the presence of tumor means that the caudal CVC 332 
tourniquet often has to be placed distal to the left renal vein insertion, therefore also 333 
requiring right and left renal vein tourniquets to create a blood-free field during the CVC 334 
venotomy for left-sided tumors. In contrast the more cranial right phrenicoabdominal 335 
vein insertion (Figure 2) means that two CVC tourniquets cranial and caudal to the tumor 336 
thrombus in the CVC will usually suffice for right-sided tumors (Figure 3). One dog with 337 
a post-hepatic CVC thrombus required extension of the surgical approach to include a 338 
median sternotomy and six vascular tourniquets to additionally isolate the thoracic post-339 
hepatic CVC and hepatic inflow (portal vein and hepatic artery).  340 
 341 
Previous studies report closure of the CVC venotomy using a partial occlusion clamp,1,2,4 342 
whereas in others the CVC venotomy and closure was performed under full occlusion,5,6 343 
although the reason for selection of either technique is not clear. In this study both 344 
methods of CVC venotomy closure were used, with the venotomy being sutured under 345 
full occlusion if the venotomy was too large to accommodate a tangential clamp or if the 346 
positioning of the clamp was impractical. For right‐sided tumors, the cranial insertion of 347 
the right phrenicoabdominal vein and subsequent proximity of the venotomy to the 348 
hepatic hilus (Figure 2) precluded easy clamp placement in some cases. Despite pre-349 
placement (prior to venotomy) of the starting knot, performing the venotomy and vein 350 
closure under full CVC occlusion resulted in a longer median CVC occlusion time 351 
compared to using a partial occlusion clamp although this method appeared to be equally 352 
well tolerated. 353 
 354 
  
Use of various suture sizes (4-0 to 5-0), material (silk, polypropylene, polydioxanone) 355 
and patterns (simple continuous, cruciate continuous) have been reported in the literature 356 
for performing the CVC venotomy closure.1,2,4-6 This study did not differ much in this 357 
respect, although the suture line was oversewn with a second simple continuous suture 358 
pattern (6/19 dogs) if felt necessary at the discretion of the surgeon.  359 
 360 
Authors of one study found a significantly higher risk of perioperative mortality if 361 
concurrent ureteronephrectomy was required as it indicated a larger, more invasive 362 
tumor,7 although ureteronephrectomy has not been identified as a risk factor in other 363 
studies.3 In this study ureteronephrectomy was performed in 5/19 dogs (26%) because of 364 
neoplastic invasion of the renal vein/kidney (Figure 5) or intra-operative damage to the 365 
left renal vein because of close proximity of the tumor. Knowledge that 366 
ureteronephrectomy was only performed with left‐sided tumors in this study is useful for 367 
preoperative surgical planning and discussion with owners. Among the four dogs that 368 
died in the peri-operative period, one dog had a ureteronephrectomy performed and it is 369 
not possible from our limited data to evaluate if ureteronephrectomy is a risk factor for 370 
mortality in dogs undergoing adrenalectomy. 371 
 372 
Information in the literature on the presentation and treatment of the most extensive 373 
adrenal tumor CVC thrombi is very limited. One study reported the extent of adrenal 374 
tumor CVC thrombus as a risk factor for perioperative mortality, with an overall 375 
mortality rate of 72% for 14 dogs undergoing CVC venotomy and 100% mortality for the 376 
seven dogs with a CVC thrombus extending beyond the hepatic hilus.3 This contrasts 377 
  
with the results of this study where all five dogs with a thrombus extending to the hepatic 378 
or post-hepatic CVC survived to discharge. The overall 21% (4/19 dogs) mortality rate in 379 
this study is similar to other studies involving venotomy,1,2,11 and all four dogs that died 380 
had pre-hepatic tumor thrombi. Successful outcomes for a number of dogs in this study 381 
were dependent on the availability of blood products, and all were dependent on 382 
receiving specialist anesthesia and critical care. The results of this study overall supports 383 
attempting surgical resection of many different types of invasive adrenal tumors, 384 
especially given the excellent long-term outcome expected from the published literature 385 
if the peri-operative period is survived.1-7 However, owners should be made fully aware 386 
of the risks and complications.  387 
 388 
The intra-operative (14/19 dogs, 74%) and post-operative (13/18 dogs, 72%) 389 
complication rates in this study were high, which is similar to other studies.1-7,10 The 390 
types of complications reported are also similar, including surgical hemorrhage, 391 
anesthetic complications, pancreatitis, azotemia/renal failure and thromboembolic 392 
complications.1-7 Very limited information is available regarding anticoagulation 393 
strategies for the prevention or treatment of thromboembolic disease in canine patients 394 
undergoing adrenalectomy with venotomy, despite pheochromocytoma, venotomy and 395 
blood transfusion all being reported as factors that increase the risk of disseminated 396 
intravascular coagulation in dogs undergoing adrenalectomy.3 In contrast to the single 397 
pre-venotomy heparin dose given in this study, one study reports the administration of 398 
heparin in plasma during surgery with continued heparin doses tapering over several 399 
days,2 but there are no studies reporting decreased incidence of thromboembolism with 400 
  
any anticoagulation protocol. Application of a topical anticoagulation solution (ice-cold 401 
lidocaine, heparin and saline) to thoroughly flush a venotomy site prior to closure is 402 
recommended in one surgical textbook.12 One uncommon complication seen in this study 403 
was temporary jejunal ischemia due to occlusion of the cranial mesenteric artery in two 404 
dogs during dissection of large left sided tumors that enveloped this artery. The ligature 405 
was removed in both cases reversing the problem but necessitating a longer dissection to 406 
preserve this artery. This problem was anticipated prior to surgery as the cranial 407 
mesenteric artery was seen to be enveloped by the left sided adrenal tumor on computed 408 
tomography (Figure 6) . Discoloration of the small intestine during adrenal tumor 409 
dissection without the cause identified has been mentioned in two other studies, one as a 410 
temporary event where the dog recovered11 and one in which fatal permanent jejunal 411 
necrosis was described.10 412 
 413 
This study had substantial limitations. Because of the retrospective nature, the sample 414 
size, completeness and type of data collected could not be controlled, and there was a 415 
smaller population of dogs with CVC thrombi extending beyond the hepatic hilus 416 
compared to those within the pre-hepatic CVC. The surgeries in this study, although from 417 
one institution, were non-standardized and performed by multiple board-certified 418 
surgeons and anesthesiologists. Multi‐institutional prospective studies with predefined 419 
surgical, anesthesia, endocrine, and anticoagulation protocols would substantially 420 
enhance the power and quality of the data that could be captured regarding surgical 421 
treatment of adrenal tumors with CVC invasion in dogs. 422 
 423 
  
In conclusion, CVC occlusion times up to eight minutes appear to be well tolerated in 424 
clinical cases of dogs undergoing adrenalectomy with CVC venotomy, similar to that 425 
reported in experimental healthy dogs, and additionally longer CVC occlusion times may 426 
also be well tolerated in some clinical cases. In contrast to other reports, dogs with CVC 427 
tumor thrombi extending beyond the hepatic hilus can survive the perioperative period. 428 
The variation in presentation of adrenal tumor thrombi and the details of surgical 429 
techniques used to treat them in this study, particularly the differences between right and 430 
left sides, provides useful additional information for surgeons planning and operating on 431 
these types of cases. Pre-operative planning is particularly important to minimize surgery 432 
time in these types of cases that are at risk of unstable anesthetics and may need a long or 433 
difficult dissection to remove the adrenal tumor, although the venotomy aspect of the 434 
procedure is very controlled and always relatively short in relation to the rest of the 435 
surgery. 436 
 437 
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Figure Legends 478 
Fig 1. Adrenal tumors typically extend down phrenicoabdominal (PA) vein and into 479 
caudal vena cava but do not adhere to the walls of the cava itself. 480 
 481 
 482 
 483 
Fig 2. Illustrations show the more distal insertion of the left phrenicoabdominal (PA) vein 484 
adjacent to the insertion of the left renal vein on the caudal vena cava (CVC) and the 485 
proximity of the right PA vein to the hepatic hilus.  486 
 487 
 488 
  
Fig 3. Right sided adrenal tumors with caval extension usually only need 2 tourniquets to 489 
isolate them. The right adrenal tumor has been dissected out until it only remains attached 490 
by the right phrenicoabdominal (PA) vein insertion on the caudal vena cava (CVC). 491 
 492 
 493 
  494 
  
Fig 4. Left sided adrenal tumors with caval extension usually require 3 to 4 tourniquets to 495 
isolate them. After dissection of the left adrenal tumor it is passed underneath the 496 
mesentery so as to be on the same side as the caudal vena cava (CVC) to facilitate final 497 
exposure for the venotomy.  498 
 499 
 500 
  501 
  
Fig 5. Left adrenal tumor compressing/invading left renal vein. A left reteronephrectomy 502 
was planned from the outset in this case.  503 
 504 
 505 
  
Fig 6. Left adrenal tumor enveloping cranial mesenteric artery.506 
 507 
